List of KaloBios Pharmaceuticals patents

List of KaloBios Pharmaceuticals patents

List of NEX Team Inc. patents

List of Glenmark Pharmaceuticals patents

List of Dovetail Genomics, Llc patents

List of companies in Solstice Capital's investment portfolio

Companies in the Recommerce industry

Patents where

Current Assignee

Name

is

KaloBios Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7981843 Antibody specificity transfer using minimal essential binding determinants	Patent 7981843 was granted and assigned to KaloBios Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	7981843	July 19, 2011
	‌ US Patent 8168183 Antibodies to granulocyte-macrophage colony-stimulating factor	Patent 8168183 was granted and assigned to KaloBios Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8168183	May 1, 2012
	‌ US Patent 8664365 Antibodies to EphA3	Patent 8664365 was granted and assigned to KaloBios Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8664365	March 4, 2014
	‌ US Patent 8044181 Antibodies to the PcrV antigen of	Patent 8044181 was granted and assigned to KaloBios Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8044181	October 25, 2011
	‌ US Patent 8075885 Methods of treating heart failure using an anti-GM-CSF antibody	Patent 8075885 was granted and assigned to KaloBios Pharmaceuticals on December, 2011 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8075885	December 13, 2011
	‌ US Patent 8398972 Methods of treating dementia using a GM-CSF antagonist	Patent 8398972 was granted and assigned to KaloBios Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8398972	March 19, 2013
	‌ US Patent 8354251 Transactivation system for mammalian cells	Patent 8354251 was granted and assigned to KaloBios Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8354251	January 15, 2013
	‌ US Patent 8211648 Secretion of antibodies without signal peptides from bacteria	Patent 8211648 was granted and assigned to KaloBios Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8211648	July 3, 2012
	‌ US Patent 9290571 Antibodies to EphA3	Patent 9290571 was granted and assigned to KaloBios Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.	KaloBios Pharmaceuticals	KaloBios Pharmaceuticals		United States Patent and Trademark Office	9290571	March 22, 2016
	‌ US Patent 8834870 Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3	Patent 8834870 was granted and assigned to KaloBios Pharmaceuticals on September, 2014 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8834870	September 16, 2014
	‌ US Patent 8642039 Method of treating a staphylococcus infection in a patient having a low-level pathogenic	Patent 8642039 was granted and assigned to KaloBios Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8642039	February 4, 2014
	‌ US Patent 8877191 Antibodies to the PcrV antigen of	Patent 8877191 was granted and assigned to KaloBios Pharmaceuticals on November, 2014 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	8877191	November 4, 2014
	‌ US Patent 9109032 Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow	Patent 9109032 was granted and assigned to KaloBios Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	9109032	August 18, 2015
	‌ US Patent 9045539 Anti-EMR1 antibodies	Patent 9045539 was granted and assigned to KaloBios Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	9045539	June 2, 2015
	‌ US Patent 9127046 Secretion of antibodies without signal peptides from bacteria	Patent 9127046 was granted and assigned to KaloBios Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.		KaloBios Pharmaceuticals		United States Patent and Trademark Office	9127046	September 8, 2015

15 results

0 selected

15 results

0 selected